Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Democratic VP Nominee Edwards Bolsters Kerry’s “Affordable Health Care” Agenda

This article was originally published in The Pink Sheet Daily

Executive Summary

Sen. Edwards is an advocate of stricter DTC regulation, generic patent law reform, comparative effectiveness research and DoJ investigation of manufacturer “price gouging.”

You may also be interested in...

Medicare Rx "Non-Interference" Provision Is Bipartisan Target, Former CMS Official Says

Statutory language prohibiting HHS from negotiating prices with drug manufacturers will likely be repealed in the next two years regardless of the presidential election's outcome, Patton Boggs partner Kathleen Means says.

“Fallback” Plan Will Be Main Medicare Rx Program, Medco Predicts

The private sector is unlikely to offer stand-alone drug insurance plans under Medicare in 2006, Medco CEO David Snow predicted during the Goldman Sachs conference in Laguna Niguel, Calif. June 9

DTC Ads Must Be "Clear And Balanced" Under Sen. Edwards Bill

The legislation is similar to an amendment Edwards proposed for the Medicare Rx bill. It also calls for NIH comparative efficacy studies and an expedited drug advertisement review process.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts